Protagonist Therapeutics (PTGX) Earnings (2015 - 2026)
Protagonist Therapeutics (PTGX) earnings from Jun 30, 2015 to Mar 31, 2026. The TTM Protagonist Therapeutics (PTGX) earnings is -$115M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Protagonist Therapeutics (PTGX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -6.47% |
| 5 Years TTM | +10.36% |
| 10 Years TTM | +20.07% |
| All Time TTM | +18.29% |
Annual Earnings change of Protagonist Therapeutics (PTGX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $3.78M | -102.90% |
| 2025 | -$130M | -147.29% |
| 2024 | $275M | -448.56% |
| 2023 | -$79M | -38.02% |
| 2022 | -$127M | +1.47% |
| 2021 | -$126M | +89.80% |
| 2020 | -$66M | -14.30% |
| 2019 | -$77M | +98.33% |
| 2018 | -$39M | +5.30% |
| 2017 | -$37M | -0.59% |
| 2016 | -$37M | +150.20% |
| 2015 | -$15M | +34.24% |
| 2014 | -$11M | N/A |
Comparison Protagonist Therapeutics (PTGX) five years earnings CAGR with competitors
Protagonist Therapeutics (PTGX) five years earnings CAGR is 10.36%.